Evidence map›Paper›PMID 39464471›Full record

ArticleACS omega2024

Modeling High Energy Molecules and Screening to Find Novel High Energy Candidates.

Mazal Rachamim, Abraham J Domb, Amiram Goldblum

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mazal RachamimMolecular Modelling and Drug Design Lab, Institute for Drug Research and Fraunhofer Project Center for Drug Discovery and Delivery, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91905, Israel.ORCID https://orcid.org/0000-0001-8093-832X
Abraham J DombThe Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91905, Israel.ORCID https://orcid.org/0000-0002-2241-7726
Amiram GoldblumMolecular Modelling and Drug Design Lab, Institute for Drug Research and Fraunhofer Project Center for Drug Discovery and Delivery, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91905, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High energy materials (HEMs) play pivotal roles in diverse military and civil-commercial sectors, leveraging their substantial energy generation. Integrating machine learning (ML) into HEM research can expedite the discovery of high-energy compounds, complementing or replacing traditional experimental approaches. This manuscript presents an application of our in-house Iterative Stochastic Elimination (ISE) algorithm to identify HEMs. ISE is a generic algorithm that produces reasonable solutions for highly complex combinatorial problems. In molecular discovery, ISE focuses on physicochemical properties to distinguish between different classes of molecules. Due to its long track record in discovering novel, highly active biomolecules, we decided to apply ISE to another type of molecular discovery: High-energy materials. Two distinct ISE models, Model A (92 HEMs) and Model B (169 HEMs), integrated non-HEMs for comprehensive analysis. The results showcase significant achievements for both Models A and B. Model A identified 69% of active molecules in Model B, of which 62% had the highest score. Model B identified 80% of active molecules in Model A, with 61% having the highest score among those 80%. Subsequently, Model C was developed, merging all active molecules (261) from Models A and B. Statistical data indicate that Model C is a high-quality model. It was used to screen and score nearly 2 million molecules from the Enamine database. We find 66 molecules with the highest score of 0.89, plus 8 with that score which are active molecules included in the learning set of Model C. From the 66 molecules, 21 (32%) contain at least one nitro group. In conclusion, this study positions the ISE algorithm as a potential tool for discovering novel HEM candidates, offering a promising pathway for efficient and sustainable advancements in high-energy materials research.

Identifiers

PMID39464471
PMCPMC11500160

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.